AI assistant
TransMedics Group, Inc. — Director's Dealing 2024
Apr 10, 2024
31201_dirs_2024-04-10_c8f63ce1-02db-47be-ac2e-fef10a4b58d3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TransMedics Group, Inc. (TMDX)
CIK: 0001756262
Period of Report: 2024-04-08
Reporting Person: Khayal Tamer I (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-04-08 | Common Stock | M | 4388 | $16.14 | Acquired | 29573 | Direct |
| 2024-04-08 | Common Stock | S | 4388 | $90.00 | Disposed | 25185 | Direct |
| 2024-04-09 | Common Stock | M | 8341 | $16.14 | Acquired | 33526 | Direct |
| 2024-04-09 | Common Stock | M | 7171 | $38.46 | Acquired | 40697 | Direct |
| 2024-04-09 | Common Stock | S | 10532 | $90.14 | Disposed | 30165 | Direct |
| 2024-04-09 | Common Stock | S | 4980 | $91.11 | Disposed | 25185 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-04-08 | Stock Option (Right to Buy) | $16.14 | M | 4388 | Disposed | 2030-02-27 | Common Stock (4388) | Direct |
| 2024-04-09 | Stock Option (Right to Buy) | $16.14 | M | 8341 | Disposed | 2030-02-27 | Common Stock (8341) | Direct |
| 2024-04-09 | Stock Option (Right to Buy) | $38.46 | M | 7171 | Disposed | 2031-02-24 | Common Stock (7171) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 14776 | Indirect |
| Common Stock | 11051 | Indirect |
Footnotes
F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.
F2: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $90.00 to $90.025, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $90.00 to $90.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F4: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $91.00 to $91.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F5: The option is fully vested.
F6: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021.